News/ News/ R&D Biosig cleared to test merimepodib plus remdesivir in COVID-19 Phil Taylor BioSig Technologies, clinical trial, coronavirus, ViralClear 0 Comment US biotech BioSig Technologies’ subsidiary ViralClear has been cleared by the FDA to start a phase 2 trial Share X Biosig cleared to test merimepodib plus remdesivir in COVID-19 https://pharmaphorum.com/news/biosig-cleared-to-test-merimepodib-plus-remdesivir-in-covid-19/
BioSig Technologies, clinical trial, coronavirus, ViralClear
0 Comment
